Role of LKB1 in lung cancer development.

British Journal of Cancer
L Makowski, D N Hayes

Abstract

Three phenotypically related genetic syndromes and their lesions (LKB1, PTEN, and TSC1/2) are identified as frequently altered in lung cancer. LKB1, a kinase inactivated in 30% of lung cancers, is discussed in this review. Loss of LKB1 regulation often coincident with KRAS activation allows for unchecked growth and the metabolic capacity to accommodate the proliferation.

References

Jan 15, 1998·Nature·A HemminkiL A Aaltonen
Mar 18, 1999·The American Journal of Pathology·E AvizienyteL A Aaltonen
Jun 25, 1999·Mechanisms of Development·K LuukkoT P Mäkelä
Apr 25, 2002·Molecular and Cellular Biology·Wengong WangMyriam Gorospe
Sep 10, 2002·Proceedings of the National Academy of Sciences of the United States of America·Derrick J RossiTomi P Makela
Nov 2, 2002·Japanese Journal of Clinical Oncology·Satoshi HiranoTakayuki Kuriyama
Mar 26, 2003·The American Journal of Gastroenterology·Thomas J McGarrityMary K Howett
Mar 17, 2004·Oncogene·Julian CarreteroMontserrat Sanchez-Cespedes
Apr 13, 2004·Oncogene·Paloma FernandezMontserrat Sanchez-Cespedes
Oct 14, 2004·Gastroenterology·Lina UddTomi P Mäkelä
Nov 16, 2004·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Kazuya TakamochiHiroyasu Esumi
Jan 11, 2005·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·A von HerbayW Back
Jan 20, 2006·British Journal of Cancer·S ForbesM R Stratton
May 19, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Nicholas HearleRichard S Houlston
Jun 8, 2006·Annual Review of Biochemistry·Dario R AlessiJose R Bayascas
Jun 21, 2006·Applied Immunohistochemistry & Molecular Morphology : AIMM·Hubert FentonPedram Argani
Sep 1, 2006·The New England Journal of Medicine·Monica M BertagnolliUNKNOWN APC Study Investigators
Sep 29, 2006·The New England Journal of Medicine·Peter B CrinoElizabeth Petri Henske
Nov 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D Neil HayesMatthew Meyerson
Feb 20, 2007·Circulation Research·Mhairi C Towler, D Grahame Hardie
Aug 7, 2007·Nature·Hongbin JiKwok-Kin Wong
Aug 23, 2007·Cancer Science·Ryoichi OnozatoTetsuya Mitsudomi
Sep 1, 2007·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Jann N SarkariaEdward B Leof
Jan 11, 2008·The New England Journal of Medicine·John J BisslerDavid N Franz
Jan 19, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ezra E W Cohen
Jan 19, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Monica M MitaAnthony W Tolcher
Apr 5, 2008·Human Mutation·Pedro P MedinaMontse Sanchez-Cespedes

❮ Previous
Next ❯

Citations

Feb 20, 2014·Proceedings of the National Academy of Sciences of the United States of America·Brandon FaubertRussell G Jones
Jul 25, 2009·Nature Reviews. Cancer·David B Shackelford, Reuben J Shaw
Jan 9, 2010·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Jae Sook SungYeul Hong Kim
Jul 2, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J-Y Blay
Aug 22, 2009·Expert Opinion on Therapeutic Targets·Xuerong Wang, Shi-Yong Sun
Aug 6, 2009·Expert Opinion on Biological Therapy·Malcolm R AlisonShahriar Islam
Jan 10, 2018·Proceedings of the National Academy of Sciences of the United States of America·Marcus D GoncalvesLewis C Cantley
Feb 15, 2012·Nature Reviews. Clinical Oncology·Sophie Postel-VinayJean-Charles Soria
Apr 26, 2019·Free Radical Research·Sung Hwan KimJeen-Woo Park
Nov 20, 2016·Cell Biochemistry and Function·Zoya TahergorabiElham Chamani
Sep 2, 2015·Acta Crystallographica. Section F, Structural Biology Communications·Sheng DingYaqin Zhu
Apr 2, 2009·Cancer Prevention Research·Jennifer R Grandis, Athanassios Argiris
Jul 8, 2018·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Sven De BruyckerSigrid Stroobants
Sep 17, 2014·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Ni ZhaoD Neil Hayes

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.